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Objectives. This study assessed the safety and diagnostic accu- 
racy of adenosine stress myocardial perfusion scintigraphy for the 
detection of coronary artery disease using single-photon emission 
computed tomography (SPECT) in patients with significant aortic 
stenosis. 
Background. Exercise cardiac stress testing in patients with 
significant aortic stenosis is generally avoided because of concerns 
for safety. In addition, those studies that have analyzed the utility 
of exercise testing both with and without myocardial thallium-201 
scintigraphy for the diagnosis of coronary artery disease have 
yielded low specificity. Currently, no safe and accurate means 
exists to noninvasively assess the presence, xtent and severity of 
coronary artery disease in patients with significant aortic stenosis. 
Methods. The study included 35 patients with moderate to 
severe aortic stenosis (mean [-+SD] aortic valve area 0.84 _+ 
0.16 cm 2, range 0.5 to 1.2; mean maximal instantaneous aortic 
valve gradient 44.4 ± 15.9 mm Hg, range 20 to 84). All patients 
underwent a 6-rain adenosine infusion (140 pg/kg body weight per 
min) protocol and either separate acquisition rest thallium-201/ 
stress technetium-99m sestamibi or stress and 4-h redistribution 
thallium-201 SPECT. Visual 20-segment SPECT analysis used a 
standard five-point scoring system from 0 (normal tracer uptake) 
to 4 (absent uptake). The SPECT results were considered abnor- 
mal if more than two segments had a stress score >2. Hemody- 
namic, electrocardiographic and clinical responses were compared 
with those in a reference group of 100 consecutive age-matched 
patients undergoing adenosine SPECT who did not have aortic 
stenosis. 
Results. Hemodynamic responses during adenosine stress test- 
ing between the study and control patients demonstrated no 
significant difference in the net change in systolic blood pressure 
(18% of baseline vs. 14%, patients with aortic stenosis vs. control 
subjects), heart rate (21% vs. 19%), rate-pressure product (0% vs. 
2%) or incidence of chest pain (23% vs. 35%) or transient second- 
(9% vs. 9%) or third-degree atrioventricular block (3% vs. 1%). In 
the 20 patients who had coronary angiography, sensitivity for 
detection of coronary artery disease was 92% (12 of 13) and 
specificity was 71% (5 of 7). 
Conclusions. In this preliminary study, adenosine was found to 
be well tolerated and diagnostically accurate in patients with 
moderate to severe aortic stenosis. 
(J Am CoU Cardiol 1995;25:99-106) 
The use of exercise cardiac stress testing in patients with 
significant aortic stenosis has been controversial. Well de- 
scribed complications ofexercise include hypotension, syncope 
(1-5) and sudden death (1,2,6). The incidence of these events 
is not well known, and some investigators have suggested that 
patients with aortic stenosis may safely undergo exercise 
testing when performed cautiously (6-8). However, a de- 
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pressed left ventricular stroke volume response to exercise with 
a concomitant decrease incardiac output is commonly found in 
patients with aortic stenosis (9,10), and published reports 
continue to counsel avoidance of exercise testing in patients 
with significant aortic stenosis (11-13). Furthermore, ischemia 
can also occur with or without coronary artery disease in 
patients with aortic stenosis (14,15). Traditional exercise lec- 
trocardiographic (ECG) and exercise thallium-201 studies, 
when performed, have been shown (6,16-18) to yield low 
specificity in detecting coronary disease among patients with 
aortic stenosis. 
Pharmacologic stress testing with adenosine offers several 
theoretic advantages over exercise in patients with aortic 
stenosis. A potent coronary vasodilator, adenosine, used in 
association with myocardial perfusion scintigraphy, has been 
shown to be highly accurate in the detection of coronary artery 
disease (19-25) but has never been tested in patients with 
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Table 1. Demographic Data 
Control 
Patients With AS Subjects p 
(n = 33) (n = 100) Value 
Age (yr) 76 _+ 15 74 _+ 9 NS 
Male gender 16 (48%) 46 (46%) NS 
Angina 17 (54%) 44 (44%) NS 
Hx HTN 21 (60%) 60 (60%) NS 
1-Lx MI 12 (36%) 41 (41%) NS 
Hx PTCA 5 (15%) 8 (8%) NS 
Hx CABG 10 (30%) 28 (28%) NS 
LVH 12 (36%) 20 (20%) NS 
Pretest prob 0.47 _+ 0.17 0.46 _+ 0.20 NS 
AV area (cm z) 0.84 _+ 0.19 
AV grad (mm Hg) 43 _+ 15 
Data presented are mean value + SD or number (%) of patients. AS = 
aortic stenosis; AV area = aortic valve area; AV grad = aortic valve gradient; 
CABG = coronary artery bypass graft surgery; HTN = hypertension; Hx : 
history of; LVH = left ventricular hypertrophy; MI = myocardial infarction; 
Pretest prob = pretest likelihood of coronary artery disease; PTCA = percuta- 
neous transluminal coronary angioplasty. 
aortic stenosis. However, because this agent does not generally 
cause a significant elevation in the rate-pressure product, 
oxygen demand oes not increase, and myocardial ischemia is 
rarely precipitated (26,27). Therefore, we hypothesized that 
patients with aortic stenosis would have a lower risk from 
cardiac stress testing with adenosine and that diagnostic spec- 
ificity for the detection of coronary artery disease might be 
improved. Thus, the purpose of this study was to assess 
preliminarily the safety and diagnostic efficacy of adenosine 
stress myocardial perfusion single-photon emission computed 
tomography (SPECT). 
Methods 
Patients. Two patient groups were included: a study group 
and a reference group. The study group included 35 consecu- 
tive patients who fulfilled the following criteria: All had 
undergone adenosine stress myocardial perfusion SPECT and 
a two-dimensional echocardiography Doppler study within 6 
months of each other and had evidence of aortic stenosis by the 
latter, with a calculated aortic valve area <1.2 cm 2 or a peak 
instantaneous aortic valve gradient >50 mm Hg, or both. 
The reference group included 100 age-matched patients 
who underwent adenosine pharmacologic stress testing. These 
patients had no clinical evidence of aortic stenosis. The 
comparative demographic data is summarized in Table 1. The 
pretest likelihood of coronary artery disease is a numeric 
variable based on age, gender, risk factors and symptom 
classification, as published previously (28,30). Table 2 de- 
scribes the clinical profile, hemodynamic and ECG variables of 
the study subjects. 
Echocardiography. All study patients underwent conven- 
tional two-dimensional echocardiography with continuous 
wave and color flow Doppler analysis. Aortic valve gradients 
were calculated using continuous wave Doppler signals ob- 
tained in the echocardiographic window that afforded the 
highest peak instantaneous velocity across the aortic valve. 
Aortic valve area was calculated using the continuity equation, 
as described elsewhere (31-35). The studies were interpreted 
by a physician who had no knowledge of the results of the 
adenosine perfusion data. 
Adenosine infusion protocol. Antianginal medications 
were maintained at their usual dosages, except for oral dipyr- 
idamole, which was withheld for 24 h. Xanthine derivatives and 
caffeine-containing products were discontinued 48 and 12 h 
before testing, respectively. The infusion was performed with 
the patient in the supine position. Adenosine was administered 
intravenously at a dose of 140 t~g/kg body weight per min for 
6 min, and a bolus of 3.5 to 4 mCi of thallium-201 or 20 to 
30 mCi of technetium-99m sestamibi was given through a 
contralateral vein at minute 3. Vital signs and a 12-lead ECG 
were recorded at baseline and every minute thereafter for at 
least 10 min. The ECG was monitored continuously (leads V 1, 
V 5 and AVF) for development of arrhythmia or ST segment 
deviation. Blood pressure was taken from the contralateral 
arm to the adenosine infusion site. The protocol allows for the 
adenosine infusion to be reduced or prematurely terminated or
for conversion with arninophylline at the discretion of the 
cardiologist performing the test. 
Acquisition of myocardial perfusion SPECT. Myocardial 
perfusion SPECT acquisition used the previously published 
methods for both thallium-201 (36) and technetium-99m ses- 
tamibi (30,37) imaging. In brief, for thallium imaging, SPECT 
acquisition was performed 10 to 15 min after completion of 
adenosine infusion. Redistribution images were performed 4 h 
after thallium injection. Reinjection of thallium (1 to 1.5 mCi) 
was performed if the patient had a previous myocardial 
infarction, ST changes on the ECG during pharmacologic 
stress or evidence of a perfusion defect on the initial thallium 
images. Late redistribution studies (18 to 72 h) were per- 
formed for patients with a 4-h nonreversible defect (38). 
Patients injected with sestamibi during adenosine stress fol- 
lowed a previously validated rest thallium/stress technetium- 
99m sestamibi separate acquisition dual-isotope myocardial 
perfusion SPECT protocol (37-39), with technetium-99m ses- 
tamibi SPECT beginning 1 h after sestamibi injection. 
SPECT Image interpretation. For purposes of visual inter- 
pretation, all short-axis and vertical long-axis tomograms were 
displayed on transparency film, with the intensity of each 
image normalized to the maximal pixel value in that image. 
The myocardial perfusion tomograms were divided into 20 
segments for each patient (37). These segments were assigned 
to six evenly spaced regions in the apical, midventricular nd 
basal slices of the short-axis views and two apical segments of 
the midvertical long-axis lice. Each segment was scored by an 
experienced observer using a previously published (37) five- 
point scoring system (0 = normal; 1 = equivocal; 2 = 
moderate; 3 = severe reduction; 4 = absent hallium-201 
uptake), without knowledge of the clinical history, ECG results 
or the results of coronary angiography. ASPECT study was 
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Table 2. Clinical Profile and Hemodynamic and Electrocardiographic Variables of 35 Study Subjects 
Heart Rate Systolic Blood 
Pt Age (yr)/ Hx of (beats/min) Pressure (mm Hg) 
No. Gender Angina Baseline Peak Baseline I~west 
Chest AV ECG AV Grad AV Area 
Pain Block Dx (mm Hg) (cm 2) 
1 77/M Y 81 95 171 112 Y 3rd A 51 0.5 
2 77/M N 62 73 190 170 N 0 E 58 0.7 
3 79/F Y 100 108 230 199 N N Nl 28 0.8 
4 87/M Y 60 77 137 116 N 0 E 55 0.6 
5 69/M N 61 77 147 114 N 0 NI 20 1.0 
6 87/17 Y 120 121 132 110 N 0 E 74 0.5 
7 88/F N 62 73 162 147 Y 0 NI 49 0.8 
8 79/M Y 65 83 153 184 N 0 NI 51 0.7 
9 85/F N 79 98 146 111 N 0 E 29 0.6 
10 89/F N 70 70 190 136 N 0 NI 56 0.7 
11 66/F N 70 94 158 120 N 0 NI 34 0.7 
12 74/M Y 72 106 174 154 Y 2nd E 67 0.9 
13 67/M Y 59 95 180 134 Y 0 NI 34 0.9 
14 64/M N 67 84 163 128 N 1st NI 40 0.9 
15 79/M N 82 94 140 112 N 0 E 32 1.2 
16 81/M N 68 75 188 154 N 1st NI 38 0.9 
17 79/F N 66 82 193 145 N 2nd E 60 0.7 
18 71/F N 91 118 151 113 Y 0 NI 31 1.2 
19 8I/M Y 72 86 107 152 N 0 NI 66 0.8 
20 74/F N 69 83 155 127 N 0 NI 84 - -  
21 81/M N 95 117 126 109 N 0 NI 23 0.9 
22 90/M N 73 86 164 132 N 0 NI 36 1.0 
23 73/M N 84 88 134 133 N 2nd NI 22 1.0 
24 83/M N 95 109 130 102 N 0 NI 58 - -  
25 81/F N 66 66 194 217 N 0 NI 56 0.8 
26 79/1= N 81 93 140 110 N 0 E 54 1.1 
27 69/F N 75 100 173 139 N 0 NI 50 0.9 
28 80/M Y 63 55 105 90 N 0 NI 31 1.0 
29 78/F N 55 84 200 174 Y 0 A 30 1.0 
30 63/F Y 64 84 225 164 N 0 NI 41 0.6 
31 90/M N 57 68 184 142 N 0 NI 24 1.0 
32 84/F Y 72 81 176 206 N 0 NI 49 0.6 
33 78/F N 82 95 129 72 Y 0 E 43 0.8 
34 78/F N 106 83 100 164 N 0 NI 58 0.7 
35 74/F Y 95 107 143 131 Y 0 NI 22 1.0 
AV = atrioventricular; ECG Dx = electrocardiographic diagnosis (NI = normal, A = abnormal, E = equivocal); N = no; Pt = patient; Y = yes; other abbreviations 
as in Table 1. 
considered abnormal if two or more segments had a stress 
score ->2. 
For the purposes of comparison between the reference and 
study groups with respect to the scintigraphic findings, two 
scintigraphic variables were used: the summed stress score and 
the summed reversibility score (40). The summed stress score 
is defined as the sum of the stress scores for the 20 segments 
analyzed, and the summed reversibility score is defined as the 
sum of the difference between the stress and rest scores for the 
20 segments analyzed. 
Each of the 20 myocardial SPECT segments was assigned to 
one of the three major coronary territories, using a previously 
published algorithm (30). 
Interpretation of clinical and ECG response to adenosine 
infusion. Any symptoms of chest discomfort, shortness of 
breath, flushing, dizziness, headache and nausea were re- 
corded both during adenosine infusion and in the recovery 
period. The ECG response was considered ischemic if 
->0.5 mm of downsloping, ->1.0 mm horizontal or ->1.5 mm of 
upsloping ST segment depression was noted at 0.08 s after the 
J point compared with the baseline ECG. These ECG changes 
were deemed borderline if the baseline ECG revealed rest ST 
segment depression secondary to left ventricular hypertrophy 
or digitalis use. Both ischemic and borderline ischemic re- 
sponses were considered to be positive ECG responses. 
Coronary angiography. Coronary angiography was only 
evaluated in the study group. There were a total of 20 patients 
who underwent coronary angiography within 6 months of 
adenosine stress myocardial perfusion imaging (mean 67 -+ 22 
days, range 1 to 190). Coronary angiography was performed 
with the standard Judkins approach, and all coronary angio- 
grams were interpreted by two experienced physicians who 
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Figure 1. Comparison of baseline 
and pharmacologic stress hemo- 
dynamic variables in the study 
(hatched bars) and reference (sol- 
id bars) groups (p = NS). PEAK = 
highest heart rate (HR) or lowest 
systolic blood pressure (SBP) re- 
corded uring adenosine infusion; 
B/MIN = beats/rain. 
were unaware of the adenosine stress scintigraphic perfusion 
results. A significant coronary stenosis was defined as ->70% 
maximal lumen diameter narrowing. 
Statistical analysis. Observational data are reported as 
mean value _+ SD when appropriate. Continuous variables 
were compared by Student  test. For categoric variables, the 
chi-square or Fisher exact est was used. For all purposes, a
two-tailed significance level of p = 0.05 was considered 
significant. 
Resu l ts  
Patient demographics. For the patients in the study group, 
the mean aortic valve area was 0.84 _+ 0.16 cm 2 with a mean 
peak valve gradient of 44.4 _+ 15.9 mm Hg (Table 1). As shown 
in Table 2, there were no differences in age and gender 
distribution between the study and reference patients. There 
were also no differences in the frequency of history of angina, 
previous myocardial infarction, coronary artery disease, ECG 
documented left ventricular hypertrophy or calculated pretest 
likelihood of coronary artery disease between the two groups. 
Hemodynamic effects of adenosine infusion. In the study 
group, systolic blood pressure decreased by a mean of 29 _+ 
16 mm Hg during testing, or 18 + 10% of the baseline value 
(range 0% to 44%). Heart rate in the study patients increased 
by a mean of 15 _+ 9 beats/min, or 21 + 14% of the baseline. 
Compared with the reference group, there was no significant 
difference in either the degree of heart rate increase (19% 
from baseline) or systolic blood pressure decrease (14% from 
baseline) induced by pharmacologic stress (Fig. 1). In addition, 
mean rate-pressure product did not increase during testing in 
the study patients (0.5 _+ 14%), and there was no significant 
difference compared with the reference patients (2.0 _+ 16%). 
To determine whether the severity of aortic stenosis had a 
direct impact on the hemodynamic response to adenosine 
stress, we further characterized the study group as those with 
an aortic valve area either more (Group A) or less (Group B) 
than the mean value of 0.84 cm 2. Group A (mean aortic valve 
area 1.0 _+ 0.1 cm 2) had a mean decrease in systolic blood 
pressure of 17 _+ 7% and a mean increase in heart rate of 25 _+ 
16% from baseline values. Group B (mean aortic valve area 
0.68 _+ 0.11 cm 2) had a decrease in systolic blood pressure of 
18 _+ 11% and an increase in heart rate of 18 + 10%. These 
differences between Groups A and B were not statistically 
significant. 
Electrocardiographic effects of adenosine infusion. Three 
(9%) of the patients with aortic stenosis developed second- 
degree heart block, and there was one patient (3%) with 
third-degree heart block in the study group. In comparison, 
nine patients (9%) in our reference group developed second- 
degree and one (1%) developed third-degree atrioventricular 
(AV) block. These differences were not statistically significant. 
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Table 3. Symptoms Experienced During Adenosine Stress Testing 
Patients Control 
With AS Subjects p 
(n - 33) (n = 100) Value 
Chest pain 8 (24%) 32 (32%) NS 
Flushing 12 (36%) 27 (27%) NS 
Dyspnea 9 (27%) 19 (19%) NS 
Headache 5 (15%) 19 (19%) NS 
Dizziness 4 (12%) 7 (7%) NS 
Nausea 1 (3%) 4 (4%) NS 
Data presented are number (%) of patients. AS = aortic stenosis. 
All episodes of heart block observed were transient and 
terminated either spontaneously or with cessation or reduction 
of adenosine infusion. 
In contrast to the reference group, ST segment depression 
in the study group, which occurred uring adenosine stress, 
was more likely to be interpreted as nondiagnostic because of 
the presence of a left ventricular hypertrophy pattern on the 
baseline ECG (9 [26%] of 35 vs. 9 [9%] of 100, p = 0.05). 
However, the incidence of definite ischemic hanges induced 
by pharmacologic testing was not different between the two 
groups (2 [6%] of 35 vs. 5 [5%] of 100, p = NS). 
Symptoms experienced uring adenosine infusion. Table 3 
outlines the incidence of the six most commonly encountered 
symptoms occurring during adenosine infusion. In the refer- 
ence patients, the symptoms, in order of decreasing frequency, 
were chest discomfort, flushing, dyspnea, headache, dizziness 
and nausea. Patients with aortic stenosis reported more flush- 
ing (36% vs. 27%) and less chest discomfort (24% vs. 32%) 
than the control patients. However, the differences were not 
found to be statistically significant. 
Incidence of adenosine protocol deviation. Four patients 
(Patients 1, 17, 12 and 30 [Table 2]) underwent an adenosine 
infusion that was either slowed or prematurely terminated in
either the third or fourth minute of the test. All had significant 
chest discomfort that resolved within 1 rain after termination 
of the test. Two patients (Patients 1 and 30) had a significant 
hypotensive r sponse (34% and 27% decrease insystolic blood 
pressure from baseline, respectively) that resolved within 1 rain 
of termination or slowing of adenosine infusion. One patient 
(Patient 12) had transient second-degree AV node block, and 
one (Patient 1) had transient hird-degree AV node block. 
Aminophylline was not required in any of our study patients. 
Mean aortic valve area of these four patients was 0.72 _+ 
0.13 cm 2, and mean aortic valve gradient was 52 _+ 9.4 mm Hg 
(p = NS vs. the remaining patients in the aortic stenosis 
group). 
Myocardial perfusion SPECT analysis. Severity of perfu- 
sion defects as measured by either the summed stress everity or 
summed reversibility score were similar for the two groups. The 
mean stress core for the patients with aortic stenosis was 11.9 _+ 
9.2, and the mean score for the reference group was 9.7 _+ 9.1 
(p = NS). Mean reversibility scores were also not significantly 
different between the two groups (8.3 +_ 7.5 vs. 6.0 +_ 6.3, patients 
with aortic stenosis vs. control subjects, p = NS). 
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Figure 2. Sensitivity and specificity for detection of coronary artery 
disease by pharmacologic stress electrocardiography (hatched bars) 
and by myocardial perfusion single-photon emission computed tomog- 
raphy (solid bars). 
Diagnostic accuracy of adenosine ECG and myocardial 
perfusion SPECT for the detection of coronary artery disease. 
Twenty of the patients with aortic stenosis underwent cardiac 
catheterization, 13 of whom (65%) had angiographically evi- 
dent coronary artery disease (->70% stenosis), and 7 (35%) 
had normal coronary arteriograms (Fig. 2). For the purpose of 
determining diagnostic accuracy, two patients with patent 
saphenous grafts in both the left and right systems were 
considered as having negative findings for coronary artery 
disease. 
Fourteen patients had a normal ECG response to adeno- 
sine stress. Only one patient had a definitively ischemic ECG 
response, and the remaining five had borderline responses due 
to rest ST segment depression. For purposes of a dichotomous 
classification, both ischemic and borderline ischemic responses 
were considered positive ECG responses. Three of the 13 
patients with coronary artery disease by angiography had a 
positive ECG response (sensitivity 23%). Of the seven patients 
with normal coronary arteriographic results, four had a normal 
stress ECG response (specificity 57%). 
For myocardial perfusion SPECT, perfusion defects were 
present in 12 of 13 patients with angiographieally significant 
coronary artery disease, yielding a sensitivity of 92% for the 
detection of coronary artery disease. Among the seven patients 
who had normal coronary arteriographic results, two had 
abnormal myocardial perfusion findings after adenosine stress, 
producing a specificity of 71%. 
Discuss ion  
Hemodynamic response during adenosine stress myocar- 
dial perfusion SPECT in patients with aortic stenosis. Many 
published reports (1-5,11-14) discuss the dangers of exercise 
testing in patients with aortic stenosis. Clyne et al. (9) showed 
that even asymptomatic patients with aortic stenosis develop a
decrease in left ventricular stroke volume and cardiac output 
during exercise. Nylander et al. (7) studied 91 patients (mean 
valve area 0.83 cm 2) and found that 38% of patients undergo- 
ing upright exercise testing developed significant hypotension. 
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Animal and human studies suggest hat the well described 
complication of syncope during exercise is caused by an 
elevation of left ventricular systolic pressure with resultant 
stimulation of left ventricular baroreceptors (1-3,41,42), re- 
flexive peripheral vasodilation (41,42) and bradycardia (2). 
Exercise-induced myocardial ischemia has been shown to 
occur in aortic stenosis, even in the absence of coronary artery 
disease. In response to stress, patients with aortic stenosis have 
a markedly reduced coronary vasodilatory reserve (14) and 
increased myocardial lactate production (15). It is reasonable 
to believe, as some have suggested (1), that the aforemen- 
tioned hemodynamic consequences of exercise may be exacer- 
bated by ischemia, with or without he presence of coronary 
artery disease. 
Pharmacologic stress testing with adenosine or dipyrida- 
mole is an attractive alternative to exercise testing in the 
patient with aortic stenosis. Because peripheral and left ven- 
tricular systolic pressures decrease during dipyridamole or 
adenosine infusion, complications of left ventricular systolic 
hypertension a d baroreceptor stimulation would be avoided. 
Furthermore, coronary blood flow increases during pharmaco- 
logic stress and scintigraphic perfusion defects are usually 
caused by only relative but not absolute decreases incoronary 
blood flow. Because the rate-pressure product has been shown 
to increase no more than 10% during pharmacologic testing 
(43), there is no significant increase in myocardial oxygen 
demand such as occurs during exercise. Although true myo- 
cardial ischemia during pharmacologic stress caused by either 
coronary steal (44) or a decrease in coronary perfusion pres- 
sure from systemic hypotension (45) has been described, the 
occurrence is far less frequent than that with exercise (26). 
There are few published reports of pharmacologic stress 
testing in patients with aortic stenosis. Huikuri et al. (46) 
described a series of 27 patients with aortic stenosis (mean 
aortic valve area 1.0 _+ 0.6 cm 2) who underwent planar thallium 
myocardial imaging after combined intravenous dipyridamole 
infusion and isometric handgrip testing. Only two patients had 
dizziness associated with a modest decrease inblood pressure, 
and two patients developed angina during handgrip testing. All 
symptoms resolved after the administration f aminophylline 
and nitroglycerin. 
Compared with dipyridamole, adenosine is a more potent 
vasodilator with a significantly higher incidence of symptoms, 
such as chest pain, dyspnea nd flushing. However, it has a 
significantly shorter half-life (<2 s), which leads to a very short 
duration of any symptoms or hemodynamic effects (24,46). 
However, it is unknown whether the symptoms or the hemo- 
dynamic response induced during adenosine stress would be 
more severe in the setting of aortic outflow obstruction. 
With respect o hemodynamic response, our results howed 
that the change in blood pressure, heart rate and rate-pressure 
product during adenosine stress among the patients with aortic 
stenosis was similar to the reference group. Of the four 
patients whose infusion protocols were modified or terminated 
early at the discretion of the physician, two had a significant 
hypotensive r sponse (34% and 27% decrease in blood pres- 
sure, respectively) toadenosine stress. However, each of these 
patients was severely hypertensive (systolic blood pressure 171 
and 225 mm Hg, respectively) at the start of the study, and 
their lowest systolic blood pressure remained >110 mm Hg. 
Although their mean aortic valve area of 0.59 cm 2 is lower than 
the mean value of the study group (0.84 cruZ), we found that 
the hypotensive and tachycardic response during adenosine 
stress in those patients with aortic stenosis with lower aortic 
valve areas (less than the mean value of 0.84 cm z) was not 
significantly different from those with a higher aortic valve area 
(>0.84 cruZ). However, to maximize safety in high risk patients 
with severe aortic stenosis, it may be prudent o begin the 
adenosine infusion at a lower dose and to increase it in a 
stepwise manner (19). 
In a recent review of the safety of adenosine stress perfu- 
sion imaging in >9,000 patients from a multicenter registry, 
Cerqueria et al. (43) reported amean increase in heart rate of 
18.9% of the baseline value, which is similar to the 19.2% 
increase seen in our reference patients. However, the mean 
change in systolic blood pressure in the registry patients was 
only 6.7%, whereas the mean decrease in systolic blood 
pressure in our reference patients was 14.1%. In addition, the 
incidence of second-degree AV block in the registry patients 
was 4%, whereas the incidence in our reference patients was 
9%. One possible explanation for these discrepancies i  that 
13% of the registry patients had a premature r duction i  the 
rate of their adenosine infusion, whereas only 3% of our 
patients' studies were similarly altered. Although adenosine 
infusions were more likely to be terminated prematurely at our 
center compared with the registry study (15% vs. 7%), 50% of 
our reference patients whose tests were terminated completed 
at least 5 rain of the 6-min infusion, and 86% completed at 
least 4 min of the protocol. 
The common symptom of chest discomfort that occurs 
during adenosine infusion is clinically difficult to distinguish 
from angina but appears very frequently even in normal 
volunteers (24,45). The origin is thought to be due at least in 
part to neurohormonal receptor stimulation (47). Given that 
this side effect occurred with essentially equal frequency in 
both the study and the reference groups, the precipitation of
chest discomfort in patients with aortic stenosis during aden- 
osine infusion is unlikely to be secondary to ischemia. The 
incidence of other common side effects, such as dyspnea nd 
flushing, was also not significantly different between the pa- 
tients with aortic stenosis and control subjects. 
Although the numbers of patients in the present study are 
small, our study suggests that adenosine myocardial perfusion 
SPECT is safe in patients with significant aortic stenosis. 
Diagnostic accuracy of adenosine stress myocardial perfu. 
sion SPECT for detection of coronary artery disease in pa- 
tients with aortic stenosis. Aside from concerns of safety, 
exercise stress testing in patients with aortic stenosis for the 
purpose of coronary artery disease detection has generally 
been found to be inaccurate with low specificity. As described 
earlier, ischemia can be precipitated in patients with aortic 
stenosis in the absence of significant coronary artery disease. 
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ST segment depression i patients with aortic stenosis i  known 
to lack specificity for the diagnosis of coronary artery disease 
(1,9,16). In addition, symptoms of angina have been unreliable 
in predicting coronary disease in these patients (6,7,48). In a 
series of patients with aortic stenosis, only 27% of those with 
angina had any coronary lesions on angiography (7). Further- 
more, many patients with significant aortic stenosis are se- 
verely limited in their ability to exercise and often do not reach 
their target heart rate. 
Because of the unreliability of anginal symptoms and stress 
ECG findings in patients with aortic stenosis, several investi- 
gators (6,17,18) have utilized exercise thallium myocardial 
perfusion imaging to assist in the detection of coronary artery 
disease. The results of these studies have also been disappoint- 
ing. Bailey et al. (6) performed exercise redistribution thallium 
studies with the planar method in 22 patients with aortic 
stenosis and described a pattern of left ventricular wall "thin- 
ning" that was thought to represent diffuse subendocardial 
ischemia unrelated to coronary disease. They concluded that 
thallium exercise testing was unable to accurately diagnose 
coronary artery disease in patients with aortic stenosis. 
Pfisterer et al. (17) described reversible apical planar perfusion 
defects in many patients with aortic stenosis without coronary 
disease and concluded that the test was therefore not specific. 
Similarly, Kupari et al. (18) found planar thallium testing to 
have a high false positive rate (specificity 57%) but suggested 
that negative test results may be helpful in excluding coronary 
artery disease. 
Because true myocardial ischemia is infrequently provoked 
during pharmacologic stress testing, we hypothesized that 
adenosine myocardial perfusion SPECT would be more accu- 
rate than conventional exercise testing in the detection of 
coronary artery disease. Our results showed that among the 
subgroup of patients with aortic stenosis who underwent 
coronary angiography in our study, adenosine stress testing 
accurately detected the presence of coronary artery disease in 
12 of 13 patients. The specificity of 71% in our small study 
group was higher than in those studies utilizing exercise testing 
in patients with aortic stenosis (6,17,18) and is consistent with 
previous reports (30,45) of the accuracy of adenosine pharma- 
cologic stress in the general nonvalvular disease test popula- 
tion undergoing myocardial perfusion SPECT. 
Because patients who have aortic stenosis, especially with 
hypertension and left ventricular hypertrophy, can have a 
decreased coronary flow reserve in normal coronary arteries 
(14,49), there is a theoretic possibility that perfusion imaging 
of heterogeneous flow patterns may be jeopardized because of 
abnormal vasodilatory reserve of patent vessels. This warrants 
consideration i  further studies with larger patient popula- 
tions. 
Indications and contraindications for adenosine myocar- 
dial perfusion SPECT in patients with aortic stenosis. Pa- 
tients with aortic stenosis will at times benefit from noninvasive 
testing for coronary artery disease. Because chest pain is often 
atypical and difficult to interpret in the patient with aortic 
stenosis, a normal noninvasivc test for coronary artery disease 
may reassure the patient as well as the physician and obviate 
the need for further workup or therapy. In those patients who 
are either not candidates for or who have refused aortic valve 
replacement surgery, a noninvasive test in a patient with 
suspected coronary artery disease may help guide the decision 
toward medical management or coronary angioplasty. Patients 
with aortic stenosis who had previous coronary artery bypass 
graft surgery or percutaneous transluminal coronary angio- 
plasty may also benefit from noninvasive testing to evaluate the 
possibility of graft closure or restenosis. Some have also 
suggested (50,51) that a sufficiently sensitive noninvasive test 
for coronary artery disease in patients with aortic stenosis 
would allow those with normal study results to proceed irectly 
to aortic valve replacement without requiring coronary angiog- 
raphy. In a small number of patients, we demonstrated a high 
degree of sensitivity and specificity. If this result holds up in a 
larger patient cohort, the presence of significant coronary 
artery disease may be ruled out by a negative test result. 
Contraindications to adenosine stress testing in patients with 
significant aortic stenosis are the same as those for the general 
test population and include significant hypotension, congestive 
heart failure, unstable angina and second- or third-degree AV 
block. 
Conclusions. On the basis of this preliminary study, aden- 
osine myocardial perfusion SPECT was found to be safe and 
diagnostically accurate for the presence of coronary artery 
disease among patients with significant aortic stenosis. 
We thank Fan Ping Wang, MD and Ishac Cohen, PhD for expert echnical 
assistance. 
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